Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Tract Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Not applicableLooking for participantsNCT07077447
What this trial is testing

The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
Zealand University Hospital 2,500
Early research (Phase 1)Not Yet RecruitingNCT07744243
What this trial is testing

SI-B036 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

Who this might be right for
Urological CancerSolid Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 30
Early research (Phase 1)Study completedNCT04580485
What this trial is testing

INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

Who this might be right for
Ovarian CancerBladder CancerNon Small Cell Lung Cancer+8 more
Incyte Corporation 54
Early research (Phase 1)Study completedNCT03752398
What this trial is testing

XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Who this might be right for
Melanoma (Excluding Uveal Melanoma)Cervical CarcinomaPancreatic Carcinoma+13 more
Xencor, Inc. 198
Testing effectiveness (Phase 2)Active Not RecruitingNCT02465060
What this trial is testing

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmBladder Carcinoma+49 more
National Cancer Institute (NCI) 6,452
Large-scale testing (Phase 3)WithdrawnNCT01724242
What this trial is testing

Vaginal DHEA for Women After Breast Cancer

Who this might be right for
Vaginal DrynessBreast CancerUrinary Incontinence+2 more
Hadassah Medical Organization
Not applicableLooking for participantsNCT07739121
What this trial is testing

Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations

Who this might be right for
Breast NeoplasmsLung NeoplasmsUrologic Neoplasms+9 more
Assistance Publique - Hôpitaux de Paris 100
Testing effectiveness (Phase 2)Looking for participantsNCT06161532
What this trial is testing

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Who this might be right for
Small Cell Carcinoma of the BladderSmall Cell Carcinoma of the Urinary TractSquamous Cell Carcinoma of the Bladder+5 more
National Cancer Institute (NCI)
Not applicableLooking for participantsNCT07101731
What this trial is testing

Effects of Hypopressive Exercises on Urinary Incontinence and Erectile Dysfunction After Radical Prostatectomy

Who this might be right for
Prostate Cancer (Post Prostatectomy)Urinary IncontinenceErectile Dysfunction Following Radical Prostatectomy+1 more
Bartın Unıversity 30
Not applicableStudy completedNCT01078545
What this trial is testing

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

Who this might be right for
Advanced Prostate CancerLower Urinary Tract Symptoms
Abbott 729
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45
Not applicableUnknownNCT04953377
What this trial is testing

PFMT Educational Intervention for Patients With Advancer Breast Cancer

Who this might be right for
Advanced Breast Cancer
Onkologikoa 42
Early research (Phase 1)Ended earlyNCT02543645
What this trial is testing

Varlilumab and Atezolizumab in Patients With Advanced Cancer

Who this might be right for
Carcinoma, Renal CellKidney DiseasesKidney Neoplasms+11 more
Celldex Therapeutics 18
Not applicableStudy completedNCT02086266
What this trial is testing

The Efficacy of Pilates in the Recovery of Post-prostatectomy Urinary Incontinence

Who this might be right for
Prostate CancerUrinary Incontinence
Universidade Estadual de Londrina 54
Not applicableLooking for participantsNCT07634666
What this trial is testing

Prediction of Myocardial Injury After Non-Cardiac Surgery in Urologic Cancer Patients

Who this might be right for
Myocardial Injury After Non-cardiac SurgeryUrologic CancerMajor Adverse Cardiovascular Events (MACE)
Korea University Anam Hospital 200
Not applicableEnded earlyNCT04393831
What this trial is testing

A Prospective Trial on Nerve Sparing Techniques Performed in Radical Prostatectomy

Who this might be right for
Prostate CancerQuality of Life
Weill Medical College of Cornell University 3
Not applicableEnded earlyNCT02538913
What this trial is testing

Exercise Training for Rectal Cancer Patients

Who this might be right for
Rectal Neoplasms
Norwegian University of Science and Technology 25
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Testing effectiveness (Phase 2)Study completedNCT00948961
What this trial is testing

CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Who this might be right for
Advanced Malignancies
Celldex Therapeutics 70
Next Page
60